Deformable liposomes coated with chitosan (DL-CS) were developed.
DL-CS could prolong pre-corneal retention and improve transcorneal penetration.
Edge activator, Solutol HS-15, could potentiate the flexibility and penetrability.
DL-CS could be a promising ocular drug delivery system.